Acker Shannon N, Ignacio Romeo, Russell Katie W, Kelley-Quon Lorraine, Lofberg Katrine, Lee Justin, Jensen Aaron R, Pickett-Nairne Kaci, Prendergast Connor, Iantorno Stephanie E, Thangarajah Hari, Patwardhan Utsav, Melhado Caroline, Zhong Allen, Padilla Ben, Rothstein David H, Nicassio Lauren, Pandya Samir, Valencia Maria, Wang Kasper, Inge Tom H
Division of Pediatric Surgery, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
Research Outcomes in Children's Surgery, Center for Children's Surgery, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.
Ann Surg. 2024 Jan 23. doi: 10.1097/SLA.0000000000006207.
Our objective was to determine the utility of enteral contrast-based protocols in the diagnosis and management of adhesive small bowel obstruction (ASBO) for children.
Enteral contrast-based protocols for adults with ASBO are associated with decreased need for surgery and shorter hospitalization. Pediatric-specific data are limited.
We conducted a prospective observational study between October 2020 and December 2022 at nine children's hospitals who are members of the Western Pediatric Surgery Research Consortium. Inclusion criteria were children aged 1-20 years diagnosed with ASBO who underwent a trial of nonoperative management (NOM) at hospital admission. Comparisons were made between those children who received an enteral contrast challenge and those who did not. The primary outcome was need for surgery.
We enrolled 136 children (71% male; median age: 12 y); 84 (62%) received an enteral contrast challenge. There was no difference in rate of operative intervention between the no contrast (34.6%) and contrast groups (36.9%; P=0.93). Eighty-seven (64%) were successfully managed nonoperatively with no difference in median length of stay (P=0.10) or rate of unplanned readmission (P=0.14). Among the 49 children who required an operation, there was no significant difference in time from admission to surgery or rate of small bowel resection based on prior contrast administration.
The addition of enteral contrast-based protocols for management of pediatric ASBO does not decrease the likelihood of surgery or shorten hospitalization. Larger randomized studies may be needed to further define the role of radiologic contrast in the management of ASBO in children.
我们的目的是确定基于肠内造影剂的方案在儿童粘连性小肠梗阻(ASBO)诊断和管理中的效用。
针对成人ASBO的基于肠内造影剂的方案与手术需求减少和住院时间缩短相关。儿科特异性数据有限。
我们于2020年10月至2022年12月在西部儿科外科研究联盟的九家儿童医院进行了一项前瞻性观察研究。纳入标准为年龄1至20岁、诊断为ASBO且入院时接受非手术治疗(NOM)试验的儿童。对接受肠内造影剂激发试验的儿童和未接受该试验的儿童进行比较。主要结局是手术需求。
我们纳入了136名儿童(71%为男性;中位年龄:12岁);84名(62%)接受了肠内造影剂激发试验。未使用造影剂组(34.6%)和造影剂组(36.9%;P=0.93)的手术干预率无差异。87名(64%)成功接受非手术治疗,中位住院时间(P=0.10)或计划外再入院率(P=0.14)无差异。在49名需要手术的儿童中,基于先前是否使用造影剂,从入院到手术的时间或小肠切除率无显著差异。
在儿科ASBO管理中增加基于肠内造影剂的方案并不会降低手术可能性或缩短住院时间。可能需要更大规模的随机研究来进一步明确放射学造影剂在儿童ASBO管理中的作用。